Ravi Viswanathan
CIK 1479386 · last filed 2022-02-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$19.26B
Companies
28
Total Filings
71
Lifetime Open-Market Net
$112.58M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DUOL | 10%+ Owner | 5,239,835 | $122.63 | $642.56M | $0 | 1 | 2022-02-16 |
| ESTC | 10%+ Owner | 1,528,117 | $60.35 | $92.22M | $0 | 1 | 2018-10-10 |
| ASND | 10%+ Owner | 82,978,668 | $218.06 | $18.09B | $49.02M | 4 | 2018-09-10 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | 10%+ Owner | 18,698,038 | $15.00 | $280.47M | $8.17M | 8 | 2018-08-22 |
| ARDX | 10%+ Owner | 3,082,186 | $5.69 | $17.54M | $23.33M | 3 | 2018-05-30 |
| Surface Oncology, Inc. (SURF) Delisted | 10%+ Owner | 3,312,877 | $1.07 | $3.54M | $2.00M | 1 | 2018-04-23 |
| TESARO, Inc. (TSRO) Delisted | 10%+ Owner | 9,681,129 | — | — | $73.31M | 6 | 2018-03-06 |
| Oruka Therapeutics, Inc. (ABIO) Delisted | 10%+ Owner | 0 | $28.80 | $0 | -$731.3K | 1 | 2018-02-27 |
| Cascadian Therapeutics, Inc. (CASC) Delisted | 10%+ Owner | 10,882,574 | — | — | $0 | 1 | 2018-02-22 |
| APPN | 10%+ Owner | 1,523 | $24.01 | $36.6K | -$66.07M | 4 | 2018-02-15 |
| SYBX | 10%+ Owner | 4,228,940 | $0.69 | $2.92M | $0 | 2 | 2018-01-26 |
| Care.com Inc (CRCM) Delisted | 10%+ Owner | 2,256,013 | — | — | $0 | 2 | 2017-11-08 |
| RYTM | 10%+ Owner | 4,359,956 | $88.38 | $385.33M | $9.35M | 1 | 2017-10-10 |
| Mersana Therapeutics, Inc. (MRSN) Delisted | 10%+ Owner | 8,140,138 | $29.08 | $236.72M | $15.00M | 1 | 2017-07-06 |
| MULESOFT, INC (MULE) Delisted | 10%+ Owner | 0 | — | — | $0 | 1 | 2017-03-22 |
| Achaogen, Inc. (AKAO) Delisted | 10%+ Owner | 5,215,128 | — | — | $6.75M | 1 | 2016-12-19 |
| Ra Pharmaceuticals, Inc. (RARX) Delisted | 10%+ Owner | 3,490,073 | — | — | $4.39M | 1 | 2016-10-31 |
| Roka BioScience, Inc. (ROKA) Delisted | 10%+ Owner | 3,216,810 | — | — | $4.60M | 3 | 2016-09-30 |
| Epizyme, Inc. (EPZM) Delisted | 10%+ Owner | 406,500 | $1.47 | $597.6K | $23.98M | 4 | 2016-01-12 |
| Avalo Therapeutics, Inc. (CERC.U) Delisted | 10%+ Owner | 594,245 | — | — | $0 | 1 | 2015-10-20 |
| SYNLOGIC, INC. (MIRN) Delisted | 10%+ Owner | 1,241,650 | — | — | $6.00M | 1 | 2015-10-06 |
| BOX | 10%+ Owner | 0 | $25.39 | $0 | $0 | 1 | 2015-01-29 |
| CVENT INC (CVT) Delisted | 10%+ Owner | 336 | $8.52 | $2.9K | -$46.25M | 5 | 2014-11-28 |
| DERM | 10%+ Owner | 3,433,810 | $6.34 | $21.77M | $1.11M | 1 | 2014-10-08 |
| Loxo Oncology, Inc. (LOXO) Delisted | 10%+ Owner | 1,789,420 | — | — | $3.00M | 1 | 2014-08-06 |
| Clovis Oncology, Inc. (CLVS) Delisted | 10%+ Owner | 11,399 | $0.08 | $926 | $17.11M | 2 | 2013-06-05 |
| WDAY | 10%+ Owner | 0 | $130.80 | $0 | $0 | 2 | 2013-04-11 |
| Millennial Media Inc. (MM) Delisted | 10%+ Owner | 8,196,614 | — | — | -$21.48M | 2 | 2012-10-30 |
Recent Filings · Page 3 of 8
71 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-01-26 | SYBX | Grant (A) | +410,000 | $4.00M | EDGAR |
| 2017-11-27 | APPN | Mixed | — | -$11.10M | EDGAR |
| 2017-11-21 | APPN | Mixed | — | -$54.97M | EDGAR |
| 2017-11-08 | Care.com Inc (CRCM) Delisted | Other (J) | −999,664 | $0 | EDGAR |
| 2017-10-10 | RYTM | Mixed | +4,880,578 | $9.35M | EDGAR |
| 2017-08-30 | SYBX | Grant (A) | +3,394,439 | $0 | EDGAR |
| 2017-07-06 | Mersana Therapeutics, Inc. (MRSN) Delisted | Mixed | +8,140,138 | $15.00M | EDGAR |
| 2017-05-31 | APPN | Conv (C) | — | $0 | EDGAR |
| 2017-03-29 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Buy (P) | +6,000,000 | $3.00M | EDGAR |
| 2017-03-28 | ASND | Buy (P) | +12,870,000 | $9.01M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.